YOLFTbeta
14

Dentium

145720 · KO · Healthcare / Medical Instruments & Supplies

37,150.00KRW-850.00 (-2.24%)

Price History

Full chart

Market Stats

Previous Close38,000.00
Open38,050.00
Day Range37,100.00 – 38,250.00
52-Week Range35,000.00 – 59,899.42
Volume31.45K
Market Cap321.50B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.62%
Beta0.60
50-Day Avg38,146.00
200-Day Avg45,508.50

About

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • Employees849
  • Headquarters21, Teheran-ro 87-gil, Seoul, South Korea, Korea
  • Websitehttps://www.dentium.co.kr

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue095.49B120.03B150.65B186.32B252.59B229.75B291.53B355.87B393.19B407.81B346.45B
Growth (%)--+25.70%+25.50%+23.68%+35.57%-9.04%+26.89%+22.07%+10.49%+3.72%-15.05%
Cost of Revenue026.89B36.75B44.03B55.54B85.01B86.95B98.38B95.19B114.35B147.56B128.40B
Gross Profit068.59B83.29B106.62B130.77B167.58B142.80B193.15B260.68B278.84B260.25B218.05B
Gross Margin-71.84%69.39%70.77%70.19%66.35%62.15%66.26%73.25%70.92%63.82%62.94%
Operating Expense-16.78B51.82B54.76B65.54B88.79B122.90B103.20B122.98B134.95B140.56B161.75B153.94B
Operating Income16.78B16.78B28.53B41.08B41.98B44.68B39.60B70.17B125.72B138.28B98.50B64.11B
Operating Margin-17.57%23.77%27.27%22.53%17.69%17.24%24.07%35.33%35.17%24.15%18.50%
EBITDA---41.20B48.37B52.14B48.88B94.00B144.14B162.80B126.72B58.97B
EBITDA Margin---27.35%25.96%20.64%21.27%32.24%40.50%41.40%31.07%17.02%
Net Income014.48B19.79B30.07B34.25B14.79B22.54B55.48B86.07B96.52B72.71B16.41B
Net Income Margin-15.17%16.49%19.96%18.38%5.85%9.81%19.03%24.18%24.55%17.83%4.74%
R&D3.84B3.84B4.68B5.25B8.40B6.51B5.02B5.45B5.63B6.87B7.65B5.59B
R&D as % of Total Revenue-4.02%3.90%3.49%4.51%2.58%2.18%1.87%1.58%1.75%1.88%1.61%
Interest Expense00001.38B5.16B8.03B6.08B6.79B7.43B9.58B10.66B
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.74%2.04%3.50%2.08%1.91%1.89%2.35%3.08%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets150.64B187.36B310.87B436.83B547.11B510.24B570.20B674.58B773.77B894.43B932.79B
Total Liabilities101.88B117.92B148.41B242.09B340.57B281.63B279.10B301.42B309.90B340.92B371.58B
Total Equity48.53B69.01B161.85B194.09B206.94B229.29B291.84B373.88B464.60B554.67B562.43B
Cash5.33B9.06B53.17B21.77B28.11B37.31B65.84B72.05B86.91B99.61B77.11B
Net Debt--44.24B171.48B239.76B178.29B125.14B129.32B115.76B151.02B206.16B

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow14.97B14.97B17.60B21.66B-574.59M-11.64B75.75B74.11B47.01B64.99B36.46B13.24B
Investing Cash Flow-28.30B-28.30B-19.13B-73.86B-111.80B-56.05B-9.25B-21.78B----
Financing Cash Flow14.87B14.87B5.22B96.45B80.19B74.61B-49.96B-24.06B----
Capital Expenditure27.85B27.85B19.00B72.33B107.43B51.26B8.62B28.18B54.11B44.15B21.66B53.56B
Free Cash Flow----51.38B-109.41B-64.08B66.66B45.07B-7.10B20.84B14.81B-40.32B
Dividends Paid425.46M425.46M607.81M607.81M1.29B1.29B1.72B1.72B2.16B2.59B3.45B5.17B
FCF to OCF----237.21%19041.02%550.43%88.00%60.81%-15.10%32.07%40.61%-304.52%
Dividend Paid to FCF----1.18%-1.18%-2.02%2.59%3.83%-30.37%12.41%23.30%-12.83%

Earnings

Report DateMay 15, 2017Aug 1, 2017Nov 14, 2017Feb 12, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 22, 2019May 15, 2019Aug 6, 2019Nov 7, 2019Feb 27, 2020May 11, 2020Aug 10, 2020Nov 10, 2020Feb 23, 2021May 17, 2021Aug 10, 2021Nov 4, 2021Mar 2, 2022May 9, 2022Aug 8, 2022Nov 8, 2022Feb 28, 2023May 9, 2023Aug 8, 2023Nov 8, 2023Feb 28, 2024May 9, 2024Aug 8, 2024Nov 7, 2024Feb 26, 2025May 8, 2025Aug 12, 2025Nov 12, 2025Feb 26, 2026Mar 31, 2026Jun 30, 2026
EPS Estimate-793.00692.50471.00256.43865.58886.10759.90765.041019.00865.19335.42101.49524.46914.59--808.001312.001312.00940.001330.602021.032336.981909.672571.302255.802644.871684.452345.392010.71-1465.89-----
EPS Actual554.121471.001199.00609.001105.001297.00787.00783.001065.001064.001288.00-1713.00387.00324.00589.001311.64985.001653.001622.002148.381808.004191.002845.001019.002124.002336.002791.003941.901938.002393.004091.002402.311463.00554.49463.27-532.071994.051645.06
Surprise-85.50%73.14%29.30%330.92%49.84%-11.18%3.04%39.21%4.42%48.87%-610.70%281.32%-38.22%-35.60%--104.58%23.63%63.75%92.34%214.97%40.77%-56.40%11.22%-9.15%23.73%49.04%15.05%2.03%103.46%--0.20%-----
Timing-Pre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market--

Key Statistics & Ratios

Market Cap321.50B
Enterprise Value540.14B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.92
Price / Book0.53
Revenue (TTM)348.09B
Gross Profit (TTM)227.72B
EBITDA94.63B
Profit Margin8.65%
Operating Margin16.44%
Return on Equity5.23%
Return on Assets4.54%
Shares Outstanding8.26M
Shares Float5.39M
Beta0.60
Dividend Yield1.62%
Dividend Rate600.00
Payout Ratio16.81%

Dividends

20261×
600.00Mar 20, 2026
20241×
600.00Dec 27, 2024
20231×
400.00Dec 27, 2023
20221×
300.00Dec 28, 2022
20211×
250.00Dec 29, 2021
20201×
200.00Dec 29, 2020
20181×
150.00Dec 27, 2018
20171×
150.00Dec 27, 2017